Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about GILD

Recent news which mentions GILD

< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Why Jim Cramer Believes Loves Berkshire Hathaway And Rivian
Tickers BRK-B GILD GM RIVN
Tags TSLA News Trading Ideas
From Benzinga
3 Biotech Stocks That Could Make You Richer in February (and Beyond)
Tickers ACET AMGN AZN GILD
Tags ACET AZN Recent Press Releases
From Motley Fool
5 Biotech Stocks to Buy to Benefit From Biden’s New Cancer Cabinet
Tickers BMY GILD LLY MRK
Tags LLY NYSE:BMY,NYSE:LLY,NYSE:PFE,NYSE:MRK,NASDAQ:GILD,NASDAQ:VERU VERU
From InvestorPlace
COVID-19 treatments raked in billions of dollars in 2021. How will they do this year?
Tickers GILD GSK LLY MRK
Tags GILD MRK VIR
From MarketWatch
How Big Are Gilead's Latest COVID Wins?
Tickers GILD PFE
Tags GILD Market News Recent Press Releases
From Motley Fool
GSK To Get $1.25B As Settlement For HIV Treatment Drug Patent Row With Gilead
Tickers GILD GSK PFE
Tags GSK Trading Ideas Health Care
From Benzinga
The Daily Biotech Pulse: LogicBio Genome Editing Therapy Study Placed On Clinical Hold, Gilead Q4 Disappoints On Slowing Veklury Sales
Tickers ABBV ARWR ATHX AVIR
Tags ABBV Penny Stocks Earnings
From Benzinga
Gilead Q4 Earnings Highlights: Remdesivir Sales Fall 30%, Raises Dividend, FY22 EPS Below Estimates
Tickers GILD
Tags Dividends General Market News
From Benzinga
Gilead Sciences (GILD) Q4 2021 Earnings Call Transcript
Tickers GILD
Tags GILD Market News Recent Press Releases
From Motley Fool
12 Health Care Stocks Moving In Tuesday's After-Market Session
Tickers AGRX BFRI CLSN ENVB
Tags Movers QSI AGRX
From Benzinga
Gilead earnings slammed by legal settlement, stock falls
Tickers GILD GSK PFE RCUS
Tags RCUS PFE JP:4507
From MarketWatch
Gilead Sciences: Q4 Earnings Insights
Tickers GILD
Tags GILD Earnings Benzinga
From Benzinga
Is AbbVie Stock a Buy Now?
Tickers ABBV GILD NVS SNY
Tags Market News NVS Recent Press Releases
From Motley Fool
What This FDA News Could Mean for Pfizer
Tickers GILD LLY MRK PFE
Tags Recent Press Releases Market News GILD
From Motley Fool
Attention Biotech Investors: Mark Your Calendar For These Key February PDUFA Dates
Tickers AGIO AMYT ATXI CTIC
Tags REGN AGIO PFE
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Tickers ALGN BMY CNC CVS
Tags Options JNJ BZI/AUOA
From Benzinga
How to Invest in Biotech When Deep Value Has no Discernible Meaning
Tickers AMGN BMY GILD
Tags BMY Market News Recent Press Releases
From Motley Fool
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
Tickers ABBV ABMD AMLX ARWR
Tags Small Cap General Benzinga
From Benzinga
Is Gilead Sciences Stock a Buy Now?
Tickers GILD
Tags GILD Recent Press Releases Market News
From Motley Fool
3 Growth ETFs to Consider Buying During This Correction
Tickers BNTX CURLF EDIT GILD
Tags IBB TCNNF MSOS
From Motley Fool
What 5 Analyst Ratings Have To Say About Gilead Sciences
Tickers GILD
Tags Market News GILD Benzinga
From Benzinga
The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data
Tickers ABT BMY CUE EW
Tags CUE NRXP Market News
From Benzinga
FDA Puts Clinical Hold On Gilead's Magrolimab/Azacitidine Combo Trials In Blood Cancer Settings
Tickers GILD
Tags Biotech Health Care Benzinga
From Benzinga
Why Sierra Oncology Stock Is On Fire Today
Tickers GILD SRRA
Tags SRRA Recent Press Releases Market News
From Motley Fool
FDA Rescinds Authorization For Regeneron, Eli Lilly COVID-19 Antibody Treatments: Here's Why
Tickers GILD LLY MRK PFE
Tags Pandemic MRK GILD
From Benzinga
A Peek Into The Markets: US Stock Futures Down Following Friday's Plunge
Tickers ABBV GILD HAL IBM
Tags A Peek Into The Markets HAL Benzinga
From Benzinga
FDA Approves Gilead's Remdesivir For Non-Hospitalized COVID-19 Patients At High Risk For Disease Progression
Tickers GILD
Tags COVID/19 Coronavirus Health Care News
From Benzinga
Everest Boosts Covid Bet With New Licensing Deal Despite Crowded Field
Tickers BNTX GILD LLY MRK
Tags General MRK Everest
From Benzinga
South Africa study shows boosters failed to block omicron, bolstering case for face masks, distancing and hand washing
Tickers BNTX GILD GSK MRK
Tags MRK PFE VIR
From MarketWatch
We need a decisive pivot on COVID-19: Double down on treatments for those at high risk instead of boosters and tests for everyone
Tickers GILD MRK PFE
Tags PFE MRK GILD
From MarketWatch
< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.